|
|
|
| Analysis of Risk Factors for Primary Arteriovenous Fistula Dysfunction in Hemodialysis Patients |
| TANG Wei, HUO Jie |
| Department of Renal Medicine, Nanchuan District Peoples Hospital, Chongqing 400000 |
|
|
|
|
Abstract 【Objective】 To explore the related factors of primary arteriovenous fistula (AVF) dysfunction in hemodialysis patients. 【Methods】 A total of 144 patients who underwent hemodialysis in our hospital were retrospectively analyzed. According to the functional status of primary AVF, 50 patients were in the dysfunction group and 94 patients were in the unobstructed group. The age, body mass index (BMI), internal fistula use time, puncture method and blood lipid index were compared between the two groups. Logistic regression analysis was used to analyze the related factors of primary AVF dysfunction in hemodialysis patients.【Results】 There were no significant differences in age, gender, BMI, duration of internal fistula, Hb, TC, DD of the dysfunction group and the unobstructed group (P>0.05). and the patency group, the thrombosis method, The ratio of button puncture and thrombosis in the dysfunction group was higher than that in the unobstructed group. The time of compression in the dysfunction group was longer than that in the unobstructed group. Levels of PLT, TG, PTH, serum calcium, blood phosphorus and serum FER in the dysfunction group were higher than those in the unobstructed group. Levels of triacylglycerol (TG) and serum calcium were in the dysfunction group were lower than those in the unobstructed. All those differences were shown statistically significant (P<0.05). Multivariate logistic regression analysis showed that thrombosis, prolonged compression time, increased TG and blood phosphorus were independent risk factors for primary AVF dysfunction in hemodialysis patients (P<0.05). 【Conclusion】 There are many factors influencing the primary AVF dysfunction in hemodialysis patients. According to the results of this study, targeted intervention is helpful to prevent the occurrence of primary AVF dysfunction.
|
|
Received: 26 August 2019
|
|
|
|
|
|
[1] Feldman ZM, Liu LB, Abramowitz SD,et al. Hemodialysis vascular access: rising costs as a surrogate marker for patency and function of arteriovenous fistulas[J].Ann Vasc Surg,2017, 38(1):136-143.
[2] Lee K, Chong T, Goh N, et al. Outcomes of arteriovenous fistula creation, effect of preoperative vein mapping and predictors of fistula success in incident haemodialysis patients: A singlea centre experience[J].Nephrology,2017, 22(5):382-387.
[3] Wernergibbings K, Ischia L, Butcher W, et al. Selective placement of autogenous arteriovenous fistulae in an over 80-year-old population[J].J Vasc Access,2018, 19(1):40-44.
[4] Alswat KA, Althobaiti A, Alsaadi K, et al. Prevalence of metabolic syndrome among the end-stage renal disease patients on hemodialysis[J].J Clin Med Res,2017, 9(8):687-694.
[5] 彭小梅, 刘园园, 吴潮清,等. 维持性血液透析患者自体动静脉内瘘失功的危险因素研究[J].中国全科医学, 2017, 20(1):67-70.
[6] 曹婷, 陈春香, 黄雪芳. 不同血管通路维持性血液透析患者的生存质量比较[J].临床合理用药杂志, 2018, 11(13):144-145.
[7] 欧月秀,秦曙光,林昌平,等. 血液透析病人自体动静脉内瘘失功能危险因素的logistic回归分析[J].安徽医药, 2019, 23(1):80-83.
[8] 熊良伟, 张祥贵. 成熟自体动静脉内瘘失功的慢性危险因素研究[J].中国血液净化, 2018, 17(5):47-52.
[9] 程博娅. 维持性血液透析患者自体动静脉内瘘失功的影响因素分析[J].中国现代药物应用, 2018, 12(20):23-25.
[10] 王嘉兴, 赵文燕, 李伟. 不同穿刺方法对血液透析动静脉内瘘临床效果及并发症的影响[J].中国药物与临床, 2017, 17(2):267-269.
[11] 任红旗, 何群鹏, 贾凤玉,等. 维持性血液透析患者血管通路使用情况分析[J].肾脏病与透析肾移植杂志, 2017, 26(3):235-239. |
|
|
|
2021, Vol. 38 
